###begin article-title 0
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
IL-4 increases type 2, but not type 1, cytokine production in CD8+ T cells from mild atopic asthmatics
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 65 67 65 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 169 171 169 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 387 389 387 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 521 523 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Virus infections are the major cause of asthma exacerbations. CD8+ T cells have an important role in antiviral immune responses and animal studies suggest a role for CD8+ T cells in the pathogenesis of virus-induced asthma exacerbations. We have previously shown that the presence of IL-4 during stimulation increases the frequency of IL-5-positive cells and CD30 surface staining in CD8+ T cells from healthy, normal subjects. In this study, we investigated whether excess IL-4 during repeated TCR/CD3 stimulation of CD8+ T cells from atopic asthmatic subjects alters the balance of type 1/type 2 cytokine production in favour of the latter.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 82 91 82 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
Peripheral blood CD8+ T cells from mild atopic asthmatic subjects were stimulated in vitro with anti-CD3 and IL-2 +/- excess IL-4 and the expression of activation and adhesion molecules and type 1 and type 2 cytokine production were assessed.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 195 197 195 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Surface expression of very late antigen-4 [VLA-4] and LFA-1 was decreased and the production of the type 2 cytokines IL-5 and IL-13 was augmented by the presence of IL-4 during stimulation of CD8+ T cells from mild atopic asthmatics.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 74 76 74 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
These data suggest that during a respiratory virus infection activated CD8+ T cells from asthmatic subjects may produce excess type 2 cytokines and may contribute to asthma exacerbation by augmenting allergic inflammation.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 276 277 276 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 699 700 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 714 716 714 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 834 835 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1231 1233 1231 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 195 203 <span type="species:ncbi:9606">children</span>
###xml 1055 1060 <span type="species:ncbi:9606">human</span>
###xml 1142 1145 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
Asthmatic airways are characterised by high levels of IL-4 due to excess Th2 responses to common aeroallergens [1-3]. Respiratory viruses are associated with 80 to 85% of asthma exacerbations in children and with 60% in adults and rhinovirus (RV) is common in all age groups [4-6]. We have found that atopic asthmatic subjects suffer from more severe and longer lasting lower respiratory tract symptoms when infected with RV than do normal subjects [7], but the mechanisms are not known. We proposed that one mechanism could be that immune responses to virus infection are type 1 deficient/type 2 augmented if they take place in a milieu rich in the type 2 cytokine IL-4 as occurs in atopic asthma [8]. Optimal CD8+ T cell responses to respiratory viruses are predominantly type 1 and over exuberant type 2 responses are detrimental [9]. Animal studies suggest that immune responses to virus infections are characterized by an increase in the frequency of type 2 cytokine-producing T cells if they take place in an allergic environment [10,11]. Data from human studies also show that an excessive type 2/deficient type 1 cytokine response to RSV-infection in the respiratory tract is associated with a more severe clinical course [12].
###end p 11
###begin p 12
###xml 45 47 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 314 316 314 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 381 383 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 707 709 703 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 844 846 840 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 36 41 <span type="species:ncbi:9606">human</span>
We have published data showing that human CD8+ T cells from both normal and asthmatic subjects have the capacity to produce type 2 cytokines [13,14]. We have recently shown that stimulation of CD8+ T cells from normal, healthy subjects in an IL-4 rich milieu significantly increased the number of IL-5-positive CD8+ T cells [15]. Due to excess Th2 immune response to allergens, CD8+ T cells from atopic asthmatic subjects are continuous exposed to IL-4 [1]. Here we investigated whether exogenous IL-4 present during TCR/CD3 stimulation modulates cell growth, surface phenotype (activation markers and adhesion molecules) and type 1 (IL-2 and IFN-gamma) and type 2 (IL-4, -5, -13) cytokine production in CD8+ T cells from atopic asthmatic subjects. We found that the presence of exogenous IL-4 during the activation of mild atopic asthmatic CD8+ T cells enhanced cell growth and increased IL-5 and IL-13 production.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Subjects
###end title 14
###begin p 15
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
###xml 384 392 <span type="species:ncbi:9606">patients</span>
###xml 659 662 <span type="species:ncbi:9685">cat</span>
###xml 671 674 <span type="species:ncbi:9615">dog</span>
Peripheral blood (40 to 50 mL) was obtained from 10 patients fulfilling clinical diagnostic criteria for asthma [16] and showing hyperreactivity to inhaled methacholine (Table 1). Asthmatic patients were classified as having mild-to-moderate asthma according to the standards of American Thoracic Society [16] and were treated with selective beta2-agonists as required. All asthmatic patients were atopic with high levels of total serum IgE (>80 IU/mL) and with positive skin prick test responses (greater than 3 mm skin wheal response) to one or more of a series of common allergens: house dust mite, mixed grass pollens, mixed tree pollens, mixed feathers, cat fur and dog hair (ALK, Denmark). None of the subjects were smokers or had a history of respiratory tract infections within the previous two months. The study was approved by Southampton Joint University and Hospital Ethics Committee.
###end p 15
###begin p 16
Characteristics of subjects
###end p 16
###begin p 17
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
*Provocative concentration of methacholine required to cause a 20% decrease in baseline forced expiratory volume in 1 second (FEV1).
###end p 17
###begin p 18
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"># </sup>
# Positive skin reactivity to a panel of common allergen (see methods)
###end p 18
###begin title 19
Antibodies and other reagents
###end title 19
###begin p 20
###xml 4 6 4 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 81 86 <span type="species:ncbi:10090">Mouse</span>
###xml 92 97 <span type="species:ncbi:9606">human</span>
"CD8+ T cell isolation" kits were from Miltenyi (Miltenyi Biotec GmbH, Germany). Mouse anti-human CD3 Abs was purified from the OKT-3 hybridoma (American Type Culture Collection, Rockville, USA). rIL-2 and rIL-4 were purchased from Genzyme (Genzyme, West Malling, Kent, UK). Leu 4 (CD3)-Peridinin Chlorophyll Protein conjugate, Leu 3a (CD4)-FITC and -phycoerythrin (PE), Leu 2a (CD8)-FITC and -PE, CD14-PE, CD16-PE, CD19-PE, CD25-FITC, CD11a (LFA-1)-FITC and CD49d (VLA-4)-PE were from Becton Dickinson (Becton Dickinson, Mountain View, CA). CD54 (ICAM-1)-FITC was from Serotec (Serotec Ltd, Oxford, UK). CD30-FITC and CD154 (CD40 ligand, CD40L)-PE were from PharMingen (PharMingen, San Diego, CA). ELISA kits were obtained from Biosource (Biosource Europe S.A., Fleurus, Belgium).
###end p 20
###begin title 21
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
CD8+ T cell purification and culture
###end title 21
###begin p 22
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 153 155 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 158 160 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 257 259 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 271 273 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 304 305 304 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 318 319 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 325 327 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
CD8+ T cells were enriched by negative immunomagnetic selection using the MACS system [17]. After passage through MACS columns, between 0.25 and 2.3 x 106 CD8+ T cells were recovered from 1 mL of blood. The resulting cell populations were routinely >98% CD3+ and >97% CD8+ and contained no detectable CD4+, CD16+, CD19+, CD14+ cells as determined by flow cytometry.
###end p 22
###begin p 23
###xml 12 14 12 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 533 534 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 877 878 876 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Purified CD8+ T cells were cultured in an antigen presenting cell-free system as previously described [15]. In brief, 0.5 x 106 cells/mL were stimulated for 3 days with plate-bound anti-CD3 Abs (10 mug/mL) in 96-well microtiter plates in RPMI 1640 culture medium supplemented with 10% FCS, 2 mM L-glutamine, 1 mM sodium pyruvate, antibiotics (all from Gibco BRL, Life Technologies, Uxbridge, UK), IL-2 (50 U/mL) with or without added IL-4 (10 ng/mL) (stimulation). After 3 days, the cells were harvested, washed, adjusted to 0.2 x 106/mL and cultured for 4 days in culture medium containing IL-2 (50 U/mL) (expansion). After every cycle of stimulation or expansion the cells were harvested and the number of live cells was determined by trypan blue exclusion and counting. After the second cycle of stimulation and expansion the cells were harvested, washed, adjusted to 1 x 106/mL and analysed.
###end p 23
###begin title 24
Cell surface markers
###end title 24
###begin p 25
###xml 180 182 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 663 664 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 667 669 659 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Following the second cycle of stimulation/expansion, the cells were harvested and washed. PerCP-, FITC-, and PE-conjugated antibodies were added to 50 mul of suspensions (0.05 x 106 cells) and incubated for 30 min at 4degreesC. After washing in PBS, stained cells were resuspended in 500 mul PBS. Flow cytometry was performed on a FACScan (Becton Dickinson, San Jose, CA). The FACScan program was used to acquire data of 10,000 events and the data were analysed by using Lysys II software. Live lymphocytes were gated by the forward scatter and side scatter pattern. Percentage in dot plots and mean fluorescence intensity (MFI) in histograms were analysed on CD3+CD8+ cells for the molecules of interest.
###end p 25
###begin title 26
Cytokine production
###end title 26
###begin p 27
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 63 64 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
After two cycles of stimulation/expansion, CD8+ T cells (1 x 106/mL) were restimulated for 24 hours with phorbol myristate acetate (PMA) (20 ng/mL) and ionomycin (2 mug/mL) or with immobilised anti-CD3 Ab. Supernatants were microfuged for 5 minutes at 400 g to remove cell debris and IL-2, IL-4, IL-5, IL-13, and IFN-gamma levels were measured by ELISA using commercial assay kits (Biosource, Europe SA). The limits of sensitivity of these assays were 3 pg/mL for IL-4, 4 pg/mL for IL-5 and IFN-gamma, 5 pg/mL for IL-2, and 12 pg/mL for IL-13.
###end p 27
###begin title 28
Statistical analysis
###end title 28
###begin p 29
###xml 89 91 89 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 268 270 268 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Paired Student t-test was used to analyse normally distributed data such as growth of CD8+ T cells cultured with or without IL-4. The Wilcoxon signed rank test for paired data was used for comparison of surface markers and for cytokine levels in culture supernatants. P values less than 0.05 were chosen for rejection of the null hypothesis.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
IL-4 amplifies the growth of CD8+ T cells from atopic asthmatic subjects
###end title 31
###begin p 32
###xml 45 47 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 628 629 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 631 633 627 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
In order to analyse the effect of IL-4 on CD8+ T cell growth we examined cell recovery after the first and second cycles of stimulation and expansion. At the end of the first cycle of stimulation/expansion there was no difference in the number of CD8+ T cells cultured with or without IL-4 (data not shown), but after the second cycle the number of cells stimulated in the presence of IL-4 was significantly higher than number of cells stimulated in the absence of IL-4 (4.5 +/- 0.7 fold increase relative to the initial population in the presence of exogenous IL-4 versus 2.9 +/- 0.7 fold increase without exogenous IL-4 (Fig. 1, P < 0.02).
###end p 32
###begin p 33
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Growth kinetics (fold increase) of CD8<sup>+ </sup>T cell numbers</bold>
Growth kinetics (fold increase) of CD8+ T cell numbers. Data are means +/- SEM (n = 10 subjects). * p < 0.02
###end p 33
###begin title 34
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
IL-4 decreases surface expression of adhesion molecules in CD8+ T cells from atopic asthmatic subjects
###end title 34
###begin p 35
###xml 48 50 48 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 273 275 273 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 364 366 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 452 454 452 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 595 597 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 651 653 651 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 672 674 672 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 803 805 803 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
As we were interested in airway responses of CD8+ T in the context of viral infection, we then investigated whether levels of expression of surface antigens associated with activation, adhesion and transmigration capabilities were altered by the presence of IL-4 during CD8+ T cell stimulation (Table 2). There was a trend to increased numbers of CD30-positive CD8+ T cells in culture with exogenous IL-4 but the difference did not reach significance (P < 0.07). However, the presence of exogenous IL-4 during stimulation induced a significant decrease in the expression (assessed by MFI) on CD8+ T cells of the adhesion molecules VLA-4 (CD29/CD49d) (P < 0.02) and LFA-1 (P < 0.05). There was a trend towards a similar reduction in ICAM-1 expression, though this did not reach statistical significance (P < 0.06).
###end p 35
###begin p 36
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Surface molecules on repeatedly stimulated CD8+ T cells*
###end p 36
###begin p 37
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 119 121 119 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 175 177 173 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
*frequency of positive cells or #mean fluorescence intensity of surface antigens after two rounds of stimulation of CD8+ T cells from atopic asthmatic subjects (mean +/- SEM; n = 7; NS, nonsignificant).
###end p 37
###begin p 38
###xml 0 7 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224; </sup>
dagger comparison between IL-4-treated and -untreated cells (paired Student's t test)
###end p 38
###begin title 39
###xml 47 49 47 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
IL-4 enhances type 2 cytokine production by CD8+ T cells from atopic asthmatic subjects
###end title 39
###begin p 40
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 118 120 118 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
To investigate whether the presence of IL-4 during CD8+ T cell stimulation alters the cytokine production pattern, CD8+ T cells harvested after two cycles of stimulation/expansion were restimulated with PMA/ionomycin or immobilized anti-CD3 Abs for 24 h to investigate cytokine synthesis and release into supenatants. The patterns of alteration in cytokine secretion following 24 h restimulation with anti-CD3 Abs (data not shown) were similar to that observed after PMA and ionomycin restimulation (Fig. 2).
###end p 40
###begin p 41
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 0 149 0 149 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Exogenous IL-4 during TCR/CD3 stimulation increased type 2 cytokine production in culture supernatants of CD8<sup>+ </sup>T cells from atopic asthmatic subjects</bold>
###xml 154 156 154 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 400 401 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
Exogenous IL-4 during TCR/CD3 stimulation increased type 2 cytokine production in culture supernatants of CD8+ T cells from atopic asthmatic subjects. CD8+ T cells were stimulated with anti-CD3 Abs+IL-2 in the presence or absence of IL-4 for 3 days followed by 4 days expansion with IL-2 alone- this cycle of stimulation/expansion was then repeated. Cells were then harvested and restimulated (1 x 106/mL) with PMA and ionomycin. Supernatants were collected after 24 hours, and cytokines measured by ELISA. Cytokine data are median (quartiles 75) of 10 atopic asthmatic subjects. * p < 0.05
###end p 41
###begin p 42
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 247 249 247 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 377 379 377 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 541 543 541 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 633 635 633 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 744 746 744 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Type 2 cytokine production by repeatedly stimulated CD8+ T cells from atopic asthmatic subjects was increased by the presence of IL-4 during stimulation (Fig. 2). There was a trend towards an increase in IL-4 (median and [range]) production by CD8+ T cells stimulated in the presence of IL-4 (without IL-4, 146 pg/mL [20 to 793 pg/mL]; with IL-4, 389 pg/mL [45 to 4309 pg/mL], P < 0.1). IL-5 levels were significantly increased by the presence of IL-4 (without IL-4, 494 pg/mL [56 to 1612 pg/mL]; with IL-4, 1251 pg/mL [391 to 10936 pg/mL], P < 0.02). IL-13 levels were also significantly increased by the presence of IL-4 during CD8+ T cell stimulation (without IL-4, 1045 pg/mL [378 to 1392 pg/mL]; with IL-4, 1455 pg/mL [580 to 5820 pg/mL], P < 0.01).
###end p 42
###begin p 43
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 312 314 308 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Excess IL-4 during repeated stimulation of CD8+ T cells did not significantly alter the levels of IL-2 (without IL-4, 2000 pg/mL [1000 to 4000 pg/mL]; with IL-4, 2135 pg/mL [1000 to 2900 pg/mL]) and IFN-gamma (without IL-4, 22 ng/mL [2 to 44 ng/mL]; with IL-4, 23 ng/mL [1 to 44 ng/mL] released in culture by CD8+ T cells.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 57 66 57 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 124 126 124 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 280 282 280 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 409 411 409 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 602 604 598 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
In this study, we show that excess exogenous IL-4 during in vitro CD8+ T cell stimulation amplified the proliferation of CD8+ T cells from atopic asthmatic subjects. Furthermore, excess IL-4 resulted in a decrease in the expression of the adhesion molecules VLA-4 and LFA-1 on CD8+ T cells, along with increased production of the type 2 cytokines IL-5 and IL-13. These data indicate that the activation of CD8+ T cells from asthmatic subjects in the presence of IL-4 increases their capacity to produce type 2 cytokines but not IFN-gamma or IL-2. These effects may be important in promoting adverse CD8+ T cell responses to virus infections in asthmatic subjects.
###end p 45
###begin p 46
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 208 210 208 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 217 219 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 293 295 293 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 359 361 359 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 434 436 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 199 204 <span type="species:ncbi:9606">human</span>
The presence of exogenous IL-4 during TCR/CD3 stimulation of peripheral blood CD8+ T cells induced expansion of cell numbers. It has previously been reported that IL-4 may act as a growth factor for human CD4+ and CD8+ T cell clones and that there is a synergy between IL-2 and IL-4 during CD8+ T cell proliferation [18]. This suggests that stimulation of CD8+ T cells in an environment rich in IL-4 may result in the expansion of CD8+ T cells when exogenous IL-2 is present.
###end p 46
###begin p 47
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 118 119 114 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 123 125 116 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 163 164 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">L</sub>
###xml 168 170 154 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 315 317 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 443 445 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 530 532 516 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 697 699 683 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 818 827 804 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 871 879 857 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 880 882 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 941 943 927 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1151 1153 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1212 1214 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1486 1495 1472 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1600 1607 1586 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
CD8+ T cells exposed to repeated stimulation in the presence of exogenous IL-4 decreased their expression of the alpha4beta1 integrin (VLA-4, CD49d/CD29) and alphaLbeta2 integrin (LFA-1, CD11a/CD18). VLA-4 is a surface marker associated with the capacity of T cells to migrate towards sites of antigen stimulation [19] and it has been previously reported that CD49d membrane expression on Th1 and Th2 clones is markedly reduced by activation [20]. The reduction in the levels of adhesion molecules as a result of activation of CD8+ T cells may play a role in the retention of activated cells at sites of antigenic stimulation. Recently, in an animal model it was reported that type 2 or type 0 CD8+ T cells had decreased surface VLA-4 density and deficient activation-induced LFA-1/ICAM-1-dependent homotypic adhesion in vitro and consequently reduced antiviral activity in vivo [21]. The presence of exogenous IL-4 during stimulation of CD8+ T cells also tended to increase the frequencies of CD30-positive cells. The expression of CD30, a member of the TNF receptor family, by T cells has been previously reported to be primarily regulated by IL-4 [22] and preferentially expressed by type 2 and type 0 cells [20]. These data collectively suggest that the presence of IL-4 in the microenvironment induces a phenotype of cells similar to tissue-resident cells and induces patterns of expression of adhesion molecules associated with adoption of type 2 function. These data suggest our in vitro observations on induction of type 2 functions more likely to truly reflect events occurring in the lungs in vivo.
###end p 47
###begin p 48
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 357 359 357 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 518 520 518 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 597 599 597 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 804 806 804 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 983 985 983 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 509 514 <span type="species:ncbi:9606">human</span>
We have found that peripheral blood CD8+ T cells from atopic asthmatic individuals, when stimulated in the presence of exogenous IL-4, released higher levels of IL-5 and IL-13 as compared with CD8+ T cells stimulated in the absence of IL-4. It has previously been reported that exogenous IL-4 increased production of IL-4 and IL-5 in stimulated neonatal CD8+ T cells [23]. However, it is now known that neonatal T cells are skewed towards a type 2 phenotype and may, therefore, not be representative of adult human CD8+ T cells [24]. We have recently reported induction of type 2 activities in CD8+ T cells from healthy adult subjects during TCR stimulation by the presence of exogenous IL-4 [15]. However, we observed only a tendency to increased IL-5-production and no increased IL-13-production in CD8+ T cells from normal subjects [[15] and unpublished data]. In the present study we extend these findings to confirm that induction by IL-4 of type 2 activities also occurs in CD8+ T cells from asthmatic subjects and demonstrate the deviation in phenotype towards type 2 is more extensive with increases in IL-5 and IL-13 production.
###end p 48
###begin p 49
###xml 88 90 88 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 172 181 172 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 222 224 222 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 380 382 380 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 428 430 428 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
Respiratory virus infections are frequently associated with asthma exacerbations and CD8+ T cells are important in anti-viral immune responses. Given the above data in our in vitro model, we suggest that stimulation of CD8+ T cells during viral infections in an environment enriched in IL-4 as occurs in asthma is likely to favour the induction of type 2 cytokine synthesis by CD8+ T cells. Production of type 2 cytokines by CD8+ T cells during immune responses to viral infections in asthma has the potential to augment allergic inflammation by a number of different mechanisms including each of the type 2 cytokines measured in this study. This hypothesis is lent credence by our recent observations that virus infection and allergen exposure are synergistic risk factors for acute exacerbations of asthma [25].
###end p 49
###begin p 50
###xml 106 108 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 436 443 424 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 732 734 716 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 780 782 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 783 785 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 856 858 840 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 865 867 849 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1073 1075 1057 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1127 1129 1111 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1208 1215 1192 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1599 1601 1579 1581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 611 615 <span type="species:ncbi:10090">mice</span>
###xml 1201 1207 <span type="species:ncbi:9606">humans</span>
By antagonising the production of IFN-gamma, type 2 cytokines may also have effects on the capacity of CD8+ T cells to clear virus. In our culture conditions, even though exogenous IL-4 did not significantly decrease the levels of IFN-gamma, the levels remained stable and the ratio of IL-4/IFN-gamma was increased (data not shown). It is quite possible that during respiratory viral infections in asthmatic relative to normal subjects in vivo, where the stimulation conditions are different, IFN-gamma production is depressed as a result of these mechanisms. This hypothesis is supported by the observation in mice that elevation of IL-4 levels concurrent with viral infections suppresses or delays activation of virus-specific CD8+ T cells and leads to delayed viral clearance [26-28]. We have previously reported a significant increase in submucosal CD4+ and CD8+ lymphocytes and in epithelial eosinophils in both normal and asthmatic subjects with experimental rhinovirus infections, and in asthmatic subjects eosinophil numbers remained elevated during convalescence [29]. These data suggest that modulation by IL-4 of CD8+ virus-specific immune responses towards a type 2 phenotype may occur in humans in vivo, and that this may be an important mechanism in virus-induced exacerbations of asthma acting both by augmenting allergic inflammation and by diminishing viral clearance. A recent rhinovirus experimental infection study has supported this hypothesis by observing impaired virus clearance and increased symptoms in subjects with increased IL-5/IFN-gamma mRNA ratios in induced sputum [30].
###end p 50
###begin title 51
Conclusion
###end title 51
###begin p 52
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 408 416 408 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 419 424 <span type="species:ncbi:9606">human</span>
In conclusion, our data demonstrate induction of type 2 cytokine production and a tissue-resident phenotype by exogenous IL-4 in CD8+ T cells from atopic asthmatic subjects. Given the excess IL-4 observed in asthma we believe that these mechanisms may play an important role in impairing virus clearance and augmenting allergic inflammation in virus-induced asthma. We are currently testing this possibility in vivo in human experimental virus infection models.
###end p 52
###begin title 53
Competing interests
###end title 53
###begin p 54
The author(s) declare that they have no competing interests.
###end p 54
###begin title 55
Authors' contributions
###end title 55
###begin p 56
LAS participated in the design of the study, performed the studies and drafted the manuscript. KR participated in the design of the study. NGP participated in the design of the study. SHC participated in the design of the study. STH conceived of the study. AJC conceived of the study. SLJ conceived of the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 56
###begin title 57
Acknowledgements
###end title 57
###begin p 58
S.L. Johnston and L.A. Stanciu thank the National Asthma Campaign and British Lung Foundation for their generous support.
###end p 58
###begin article-title 59
Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma
###end article-title 59
###begin article-title 60
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia
###end article-title 60
###begin article-title 61
###xml 87 95 <span type="species:ncbi:9606">children</span>
Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma
###end article-title 61
###begin article-title 62
###xml 88 96 <span type="species:ncbi:9606">children</span>
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children
###end article-title 62
###begin article-title 63
Respiratory viruses and exacerbations of asthma in adults
###end article-title 63
###begin article-title 64
Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma
###end article-title 64
###begin article-title 65
Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study
###end article-title 65
###begin article-title 66
A defective type 1 response to rhinovirus in atopic asthma
###end article-title 66
###begin article-title 67
Cell-mediated immunity to respiratory virus infections
###end article-title 67
###begin article-title 68
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia
###end article-title 68
###begin article-title 69
Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness
###end article-title 69
###begin article-title 70
###xml 46 73 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis
###end article-title 70
###begin article-title 71
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 78 80 78 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Production of IL-8 and IL-4 by positively and negatively selected CD4+ and CD8+ human T cells following a four-step cell separation method including magnetic cell sorting (MACS)
###end article-title 71
###begin article-title 72
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Increased levels of IL-4 in CD8+ T cells in atopic asthma
###end article-title 72
###begin article-title 73
###xml 38 43 <span type="species:ncbi:9606">human</span>
Induction of type 2 activity in adult human CD8 Tcells by repeated stimulation an IL-4
###end article-title 73
###begin article-title 74
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease and asthma
###end article-title 74
###begin article-title 75
Isolation of T-cell subsets by magnetic cell sorting (MACS)
###end article-title 75
###begin article-title 76
###xml 49 54 <span type="species:ncbi:9606">human</span>
Recombinant interleukin 4 promotes the growth of human T cells
###end article-title 76
###begin article-title 77
Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue
###end article-title 77
###begin article-title 78
Markers of Th1 and Th2 cells
###end article-title 78
###begin article-title 79
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
CD8+ T cells secreting type 2 lymphokines are defective in protection against viral infection
###end article-title 79
###begin article-title 80
Reciprocal regulation of CD30 expression on CD4
###end article-title 80
###begin article-title 81
###xml 32 37 <span type="species:ncbi:9606">human</span>
In vitro maturation of neonatal human CD8 T lymphocytes into IL-4 and IL-5-producing cells
###end article-title 81
###begin article-title 82
###xml 68 76 <span type="species:ncbi:9606">children</span>
Development of allergen-specific T-cell memory in atopic and normal children
###end article-title 82
###begin article-title 83
Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study
###end article-title 83
###begin article-title 84
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Interleukin-4 causes delayed virus clearance in influenza virus-infected mice
###end article-title 84
###begin article-title 85
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 77 104 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus
###end article-title 85
###begin article-title 86
Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses
###end article-title 86
###begin article-title 87
Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects
###end article-title 87
###begin article-title 88
Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection
###end article-title 88

